Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Coeur Commences Drilling at Silver North's Tim Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc V.VIV.H

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


TSXV:VIV.H - Post by User

Avivagen Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by drilltip1on Feb 23, 2012 12:28pm
89 Views
Post# 19573849

RE: RE: RE: RE: Carbanx

RE: RE: RE: RE: Carbanx

I don't know what the dollar potential is for the chewable tablets for dogs is in the USA but I imagine when we get introduced into the feed supply for poultry and swine the dollar value is quite large.

It's clear however that the market sees this at 13 cents or so for the time being, it will take a couple months is a logical guess to really get it moving, todays news said Later this year for the implimentation of the tablets, does that mean November or July or something like that, the market obvioulsly feels there is lots of time to get in as the trading activity would indicate.

This will be news driven that's for sure so all we need is time. Is it a fair bet that CFR will be showing some revenue in calander Q4, any thoughts on that or will it show in Q1 2013

 

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities